CTRI/2021/08/035342已完成未知
Pleiotropic effects of Teneligliptin versus Glimepiride as add on therapy to Metformin on Inflammatory biomarker hsCRP and Insulin resistance : An open-labelled randomized controlled trial
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Type 2 Diabetes patients not controlled by Metformin alone (with HbA1C > 7% )
- •Age > 20 years and < 60 years
- •Both male and female gendersÂ
排除标准
- •Type 2 Diabetes patients who are already on any DPP4 inhibitors & Metformin combination therapy or on Insulin or any other incretin based therapy or any hypoglycaemic agents
- •Patients with any acute inflammatory/ infective condition with CRP > 10 mg/L and any history of acute infection/ inflammation in past 3 monthsÂ
- •Patients with chronic inflammatory conditions, autoimmune diseases, Neoplasia
- •Patients with serious macrovascular complications such as acute MI, angina or stroke within six months of enrolment
- •Type 1 Diabetes patients or any other form of diabetes
- •Pregnant or Breastfeeding females
研究者
相似试验
尚未招募
不适用
Study of antidiabetic drugs on markers of inflammation in type 2 diabetes mellitus patients.CTRI/2018/03/012603MALEHA BUT
已完成
不适用
The examination of the effects of Teneligliptin on blood glucose and albuminuria in type 2 diabetic patients with nephropathy, whose glycemic control is insufficient.Type 2 diabetic patients with nephropathyJPRN-UMIN000015922Kanazawa Medical University50
已完成
不适用
The efficacy of teneligliptin in patients with type 2 diabetes mellitusdiabetes mellitusJPRN-UMIN000028763Juntendo University Urayasu Hospital30
招募中
不适用
A study to understand the combined effect of sitagliptin and teneligliptin with metformin in comparison to metformin alone treatment on blood glucose cotrol in patients with type 2 diabetes mellitus.CTRI/2018/03/012413Department of Pharmacology and Therapeutics
已完成
不适用
Comparison of efficacy of Teneligliptin and Sitagliptin for glucose fluctuation in Type 2 diabetesType 2 diabetesJPRN-UMIN000022885niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine20